Axiety. Anxiety disorder, unspecified
Conditions
Interventions
Intervention 1: Before the intervention, all the participants who were interested in taking part in the research and had the inclusion criteria, filled out the Speilberger?s anxiety inventory and indi
Sedamin capsules were used in this study which contained dried root and risome powder of Valeriana Officinalis, produced by Esfahan Goldaroo company which is more stable in comparison with its other d
in this laboratory, ineffective lactose powder was used to fill the placebo capsules. Personal and telephonic follow ups were done by the researcher in order to make sure of participants? drug consump
Treatment - Drugs
Before the intervention, all the participants who were interested in taking part in the research and had the inclusion criteria, filled out the Speilberger?s anxiety inventory and individuals who had
The control group was given the placebo with the same shape, taste, size and period of consumption as Valerian capsules. Regarding the distinct and specific odor of Valerian, Valerian and placebo caps
Sponsors
Vice chancellor for research, Zanjan University of Medical Scinces
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Working in intensive care units at least for one month; endorsing informed consent form; not having any diagnostic physical and mental disease; not using any sedatives, hypnotics, barbitorates, benzodiazepines, narcotics or alcohol; getting score 20 from Speilberger´s anxiety inventory that means having anxiety; not using other relaxant methods like aromatherapy, yuga, acupuncture and so on; not being pregnant or breast feeding. Exclusion criteria: Getting score 20 and less than 20 that means not having anxiety according to Speilberger´s anxiety inventory; not using valerian or placebo during study or on the other hand not cooperating; pregnancy diagnosing; outbreaking severe side effects and participant´s no tendency to continue the trial.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: Before intervention and one week after intervention. Method of measurement: Using the Spielberger State -Trate Anxiety inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety decrease. Timepoint: one week after begining of intervention. Method of measurement: Speilberger's anxiety inventory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Kourosh Amini
Zanjan University of Medical Sciences
Outcome results
None listed